HelloType1 also supports healthcare professionals through Type 1 Diabetes continuing education. Join us!

Webinars

A4D Research and Publications

With almost a decade in frontline operation through close collaboration with local healthcare partners, A4D has gained critical insights into the state of Type 1 Diabetes across South-East Asia. We have collected robust database realted to Type 1 Diabetes management and outcomes through our systematic approach on programme monitoring and tracking. In 2021, A4D initiated the effort on data analysis with the voluntary support from the A4D HCP Advisory Group, aiming to publish evidence based findings and meaningful insights on Type 1 Diabetes care in South-East Asia.

Internet analytics of an innovative digital educational resource of type 1 diabetes HelloType1 in local languages for people living with diabetes families and healthcare professionals in Southeast Asia

Author: Steffen Tange , Assoc Prof Emeritus Nguyen Thy Khue , Assoc Prof Dr Iv Malene , Assoc Prof Dr Azriyanti Anuar Zaini , Lucas Lim , Prof Taninee Sahakitrungruang , Professor May Ng, OBE , Khuong Le , Anne-Charlotte Ficheroulle

There is minimal data of health outcomes for Type 1 Diabetes (T1D) in Southeast Asia (SEA) where government funding of insulin and blood glucose monitoring either do not exist or is limited. The full impact of Covid-19 pandemic on the national economies of SEA remain unknown. In the midst of the pandemic, in 2021, HelloType1 was developed by Action4Diabetes (A4D), a non-government organisation charity in collaboration with Southeast Asia local healthcare professionals as an innovative digital educational resource platform of T1D in local languages.

HelloType1 was launched in Cambodia, Vietnam, Thailand and Malaysia in 2021 to 2022 with Memorandums of Understandings (MOUs) signed between A4D and each country. Internet data analytics were undertaken between the 1st of January 2022 to 31st of December 2022.

Publication: BMC Endocrine Disorders

Reference: BMC Endocrine Disorders (2023) 23:249

Our partners